Autophagy, Mitophagy and MicroRNA Expression in Chronic Hepatitis C and Autoimmune Hepatitis
Open Access
- 2 March 2020
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 26 (4) , 2143-2151
Abstract
Although the role of autophagy has been implicated in several forms of chronic hepatitis, it is still not fully understood. Active autophagy eliminates damaged molecules and organelles (such as mitochondria) by lysosomal degradation. In the present study, we aimed to examine and compare autophagy activity in chronic hepatitis C (CHC) and autoimmune hepatitis (AIH) by detecting the expression of autophagy (LC3 and p62) and mitochondrium-related (TOMM20) proteins, as well as the levels of selected microRNAs (miR-101, -155, -204 and − 224) known to be involved in the regulation of autophagy. In addition, the expression levels were related to pathohistological parameters. Liver biopsy samples, including 45 CHC and 18 AIH cases, were immunohistochemically stained for LC3, p62 and TOMM20 and the expression of miRNAs was determined using real-time PCR. We found elevated LC3 and p62 in AIH samples as compared with CHC ones, indicating an activated autophagy that is impaired in AIH as no degradation of p62 seemed to occur. Moreover, p62 showed strong correlation with necroinflammatory grades in the AIH group. The observed elevated levels of TOMM20 and p62 suggest a less efficient elimination of damaged mitochondria in AIH as opposed to CHC, in which autophagy seems to have a more active function. The level of miR-101 was increased in case of CHC as compared with AIH, however, miR-155, -204 and 224 resulted in no expressional. Furthermore, miR-224 level correlated with steatosis and miR-155 expression with fibrosis stage in CHC. In conclusion, dissimilar autophagic activity was observed in CHC and AIH, suggesting a close association between impaired autophagy and severity of necroinflammation. This impairment may not be regulated by the analyzed miRNAs. Nevertheless, miR-224 and − 155 seem to be associated with CHC progression.Keywords
Funding Information
- OTKA (108548)
- OTKA (128881)
- NVKP (NVKP_16_1-2016-0004)
- EFOP (EFOP-3.6.3-VEKOP-16-2017-00009)
This publication has 51 references indexed in Scilit:
- Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironmentCell Cycle, 2013
- Functions of autophagy in normal and diseased liverAutophagy, 2013
- Autophagy Protects Cells From HCV-Induced Defects in Lipid MetabolismGastroenterology, 2012
- Autophagy and disease: always two sides to a problemThe Journal of Pathology, 2011
- microRNA‐101 is a potent inhibitor of autophagyThe EMBO Journal, 2011
- Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitroJournal of Clinical Investigation, 2011
- Autophagy in liver diseasesJournal of Hepatology, 2010
- Evaluation and Validation of Total RNA Extraction Methods for MicroRNA Expression Analyses in Formalin-Fixed, Paraffin-Embedded TissuesThe Journal of Molecular Diagnostics, 2008
- Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data SetsCancer Research, 2004
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995